Search Ontology:
ChEBI
posaconazole
- Term ID
- CHEBI:64355
- Synonyms
-
- 2,5-anhydro-1,3,4-trideoxy-2-(2,4-difluorophenyl)-4-({4-[4-(4-{1-[(2S,3S)-2-hydroxypentan-3-yl]-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl}phenyl)piperazin-1-yl]phenoxy}methyl)-1-(1H-1,2,4-triazol-1-yl)-D-threo-pentitol
- Noxafil
- posaconazole
- Sch 56592
- SCH56592
- Schering 56592
- Definition
- An N-arylpiperazine that consists of piperazine carrying two 4-substituted phenyl groups at positions 1 and 4. A triazole antifungal drug.
- References
-
- CAS:171228-49-2
- DrugBank:DB01263
- Drug_Central:3483
- KEGG:D02555
- PMID:21762211
- PMID:21967490
- PMID:22058198
- PMID:22176629
- PMID:22215361
- PMID:22215487
- PMID:22286158
- PMID:22290952
- PMID:22303909
- PMID:22324990
- PMID:22330929
- PMID:22380765
- PMID:22391464
- PMID:22391534
- PMID:22427614
- Patent:US5661151
- Patent:WO9517407
- Reaxys:8379448
- Wikipedia:Posaconazole
- Ontology
- ChEBI ( EBI )
- is a type of
- has_role
-
Phenotype
Phenotype resulting from posaconazole
Phenotype where environments contain posaconazole
Phenotype modified by environments containing posaconazole
Human Disease / Model Data